Our leadership team has extensive experience in developing, obtaining regulatory approvals for and successfully commercializing a variety of oncology products. In total, they have decades of combined experience spanning a range of cancers and other diseases.

Jennifer Jackson, Ph.D.

Senior Vice President, Global Regulatory Affairs & Quality Assurance

Jennifer Jackson, Ph.D has served as Senior Vice President, Global Regulatory Affairs and Quality Assurance since June 2015. Prior to joining TESARO, Dr. Jackson was Senior Vice President, Regulatory Affairs at Cubist Pharmaceuticals. She previously served as Vice President, Regulatory Affairs and Clinical Quality at Biogen Idec Hemophilia and before that was Vice President, Regulatory Affairs at Vertex Pharmaceuticals. She has more than twenty years of experience in global development and registration of small molecules and biologics in multiple therapeutic areas. Dr. Jackson received her doctoral degree in genetics from Cornell University, and her bachelor's in biology from Reed College. She completed her post-doctoral training at the Massachusetts Institute of Technology.